NCT05075174

Brief Summary

Progesterone level has been studied at days before embryo transfert. But, progesterone blood level has not been studied 15 days after embryo transfert. The aim of this study is to study progesterone level impact at 15 days after embryo transfert on evolving pregnanies or early miscarriages.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
540

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2020

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

September 18, 2021

Completed
24 days until next milestone

First Posted

Study publicly available on registry

October 12, 2021

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

October 12, 2021

Status Verified

September 1, 2021

Enrollment Period

10 months

First QC Date

September 18, 2021

Last Update Submit

September 29, 2021

Conditions

ART

Keywords

betaHCG +pregnancy development knowprogesterone levelmiscarriage

Outcome Measures

Primary Outcomes (1)

  • number of blood progesterone

    blood progesterone at day 15 after embryo transfert

    1 day

Eligibility Criteria

Age18 Years - 43 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

ART program in Montpellier hospital \>18 years old Blood progesterone level 15 days after embryo transfert Pregnancy development know

You may qualify if:

  • ART program in Montpellier hospital
  • age \>18 years old
  • Blood progesterone level 15 days after embryo transfert
  • Pregnancy development know

You may not qualify if:

  • \- non uterine pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uhmontpellier

Montpellier, 34295, France

RECRUITING

MeSH Terms

Conditions

Abortion, Spontaneous

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Noémie Ranisavljevic, M.D., Ph.D

    University Hospital, Montpellier

    STUDY DIRECTOR

  • MARIE DUPORT PERCIER

    University Hospital, Montpellier

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Noémie Ranisavljevic, M.D., Ph.D

CONTACT

06 37 10 89 38n-ranisavljevic@chu-montpellier.fr

MARIE DUPORT PERCIER, assistante

CONTACT

0467336427m-duportpercier@chu-montpellier.fr

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2021

First Posted

October 12, 2021

Study Start

November 1, 2020

Primary Completion

September 1, 2021

Study Completion

June 1, 2022

Last Updated

October 12, 2021

Record last verified: 2021-09

Locations

FR(1)